[News Brief] Bristol Myers Squibb Names Singapore as Pan Asia Hub
Bristol Myers Squibb (BMS) has recognised Singapore as its new Pan Asia Cluster (PAC) hub, supported by the Singapore Economic…
Global PR
[News Brief] UCL and Eisai Extend Neurodegenerative Disease Research Partnership
University College London (UCL) and Eisai Co., Ltd. have signed a new agreement extending their collaboration in drug discovery and…
[News Brief] Cadila Pharmaceuticals and Wellesta Holdings Sign Joint Venture MoU
Cadila Pharmaceuticals and Wellesta Holdings have signed a memorandum of understanding to establish a strategic joint venture focused on commercialising…
[News Brief] China NMPA Standardises Medical Device Reclassification Procedures
China’s National Medical Products Administration (NMPA) has issued Announcement No. 52/2026, establishing a procedural framework to standardise the management of…
[News Brief] Abbisko Expands R&D Collaboration with Eli Lilly
Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with Eli Lilly and Company to discover and…
[News Brief] Haisco Licenses Drug Candidates to Nuvectis
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with US-based biotechnology company Nuvectis for two internally developed clinical-stage…
[News Brief] CeleCor Completes FDA Application for Heart Attack Drug
CeleCor Therapeutics has completed its New Drug Application (NDA) submission to the US Food and Drug Administration (FDA) for investigational…
[News Brief] IHLD MedTech Secures Strategic Investment from UltraGreen.ai
IHLD MedTech has secured an initial investment commitment from Singapore-listed healthcare technology firm UltraGreen.ai to support the growth of its…
[News Brief] AnHorn Medicines Secures Regulatory Clearances for AH-008
AnHorn Medicines has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration and Index Case designation…
[News Brief] Sonire Therapeutics Receives NEDO Support for HIFU Platform
Sonire Therapeutics KK has received funding through Japan’s New Energy and Industrial Technology Development Organization (NEDO) Deep-Tech Startups Support Program…